Published in Drug Law Weekly, May 17th, 2005
GelStat Arthritis is the company's second over-the-counter product and, like GelStat Migraine, utilizes the company's patent pending formulation in combination with a sublingual (under the tongue) delivery system.
"GelStat is committed to the development and commercialization of advanced OTC medications for the safe and effective treatment of pain and inflammation," said Stephen Roberts, MD, chairman and chief executive officer of GelStat. "Since inception, our research has focused on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.